APPLICATION
NDA014242
TYPE
NDA
ORIGINAL APPROVAL
1965-12-17
LATEST ACTION
2007-12-07
ROUTE
NASAL
DOSAGE FORM
AEROSOL
MARKETING STATUS
Discontinued
Products
DEXACORTDiscontinued
DEXAMETHASONE SODIUM PHOSPHATE EQ 0.1MG PHOSPHATE/INH · AEROSOL · NASAL
Approval history
2007-12-07Labeling · Supplement 28AP
2007-12-07Labeling · Supplement 26AP
2007-12-07Labeling · Supplement 32 · standardAP
2007-12-07Labeling · Supplement 24AP
2007-12-07Labeling · Supplement 22AP
2007-12-07Labeling · Supplement 14AP
2007-12-07Labeling · Supplement 27AP
2007-12-07Labeling · Supplement 19AP
2007-12-07Labeling · Supplement 33 · standardAP
2007-12-07Labeling · Supplement 31 · standardAP
2007-12-07Labeling · Supplement 23AP
2007-12-07Labeling · Supplement 21AP
1995-07-10Manufacturing (CMC) · Supplement 34 · standardAP
1994-05-03Labeling · Supplement 30 · standardAP
1991-09-11Manufacturing (CMC) · Supplement 29 · standardAP
1989-05-18Labeling · Supplement 25AP
1981-11-18Labeling · Supplement 20AP
1979-08-17Labeling · Supplement 18AP
1979-08-06Labeling · Supplement 16AP
1978-10-19Labeling · Supplement 13AP
1977-09-12Labeling · Supplement 11AP
1965-12-17Type 5 - New Formulation or New Manufacturer · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.